Study evaluated bio-based succinic acid for skin renewal and barrier maintenance, indicating effective exfoliation.
Bio-based succinic acid (bSU) has emerged as a promising mild exfoliating agent, yet its effects on desquamation pathways, barrier-related protein regulation, and irritation potential remain insufficiently characterized in human-relevant skin models. Therefore, this study systematically evaluated bSU against salicylic acid (SA) using reconstructed human epidermis and human skin explants to assess irritation profile and desquamation-related biological responses. Our findings reveal that bSU facilitates controlled corneocyte shedding by modulating the targets LEKTI, KLK, and CDSN. Moreover, bSU demonstrated a favorable ability to maintain physiological skin surface acidity, all while minimizing inflammatory activation. These results position bSU as a balanced exfoliating bioactive that effectively promotes stratum corneum renewal while preserving cutaneous barrier homeostasis, providing mechanistic insights to support its development in advanced mild exfoliation formulations.
No takes yet. Share an insight, caveat, or question.
Louvet-Pommier et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: